- Home
- GHRS vs LQDT Comparison
GHRS vs LQDT Comparison
Compare GHRS & LQDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- LQDT
- Stock Information
- Founded
- GHRS 2018
- LQDT 1999
- Country
- GHRS Ireland
- LQDT United States
- Employees
- GHRS N/A
- LQDT N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- LQDT Catalog/Specialty Distribution
- Sector
- GHRS Health Care
- LQDT Consumer Discretionary
- Exchange
- GHRS Nasdaq
- LQDT Nasdaq
- Market Cap
- GHRS 737.5M
- LQDT 773.6M
- IPO Year
- GHRS 2021
- LQDT 2006
- Fundamental
- Price
- GHRS $14.76
- LQDT $24.90
- Analyst Decision
- GHRS Strong Buy
- LQDT Strong Buy
- Analyst Count
- GHRS 8
- LQDT 2
- Target Price
- GHRS $30.63
- LQDT $38.50
- AVG Volume (30 Days)
- GHRS 204.8K
- LQDT 280.1K
- Earning Date
- GHRS 05-08-2025
- LQDT 08-07-2025
- Dividend Yield
- GHRS N/A
- LQDT N/A
- EPS Growth
- GHRS N/A
- LQDT 23.09
- EPS
- GHRS N/A
- LQDT 0.79
- Revenue
- GHRS N/A
- LQDT $439,246,000.00
- Revenue This Year
- GHRS N/A
- LQDT $35.02
- Revenue Next Year
- GHRS N/A
- LQDT $9.90
- P/E Ratio
- GHRS N/A
- LQDT $30.65
- Revenue Growth
- GHRS N/A
- LQDT 35.78
- 52 Week Low
- GHRS $6.00
- LQDT $19.31
- 52 Week High
- GHRS $20.50
- LQDT $39.72
- Technical
- Relative Strength Index (RSI)
- GHRS 66.16
- LQDT 49.55
- Support Level
- GHRS $11.82
- LQDT $23.25
- Resistance Level
- GHRS $12.94
- LQDT $24.09
- Average True Range (ATR)
- GHRS 0.99
- LQDT 0.69
- MACD
- GHRS 0.19
- LQDT 0.23
- Stochastic Oscillator
- GHRS 84.53
- LQDT 96.47
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About LQDT Liquidity Services Inc.
Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.